JPMorgan raised the firm’s price target on Agilent (A) to $180 from $165 and keeps an Overweight rating on the shares. The company reported a fiscal Q4 sales beat with revenue guidance above expectations, the analyst tells investors in a research note. The firm sees Agilent as a “clean tools story to own” into fiscal 2026. The company is in the middle of two separate instrument replacement cycles with potential upside from reshoring in both businesses over the long term, contends JPMorgan.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on A:
- Agilent price target raised to $185 from $165 at Citi
- Agilent price target raised to $165 from $145 at Barclays
- Agilent Technologies: Balanced Outlook with Hold Rating Amid Mixed Financial Signals
- Closing Bell Movers: Zoom up 4% on earnings beat
- Agilent down 2% at %150.54 after Q4 results and guidance